105
Participants
Start Date
September 30, 2006
Primary Completion Date
August 31, 2013
Study Completion Date
August 31, 2013
Bosentan
Bosentan + Placebo for 12 weeks of the study (double blind), then 12 months open label phase (bosentan + sildenafil)
Placebo
Bosentan + Placebo for 12 weeks of the study (double blind), then 12 months open label phase (bosentan + sildenafil)
Bosentan
Bosentan + Sildenafil for 12 weeks of the study (double blind), then 12 months open label phase
Sildenafil Citrate
Bosentan + Sildenafil for 12 weeks of the study (double blind), then 12 months open label phase
Department of Surgery, National Taiwan University Hospital, Taipei
St. Vincents Hospital, Darlinghurst
The Prince Charles Hospital, Chermside
Attikon Hospital, Haidari
Unfallkrankenhaus Berlin, Klinik fuer Innere Medizin, Berlin
Allegheny General Hospital, Pittsburgh
Medizinische Hochschule Hannover, Hanover
Rambam Medical Center, Haifa
Universitaetsklinikum Giessen und Marburg GmbH, Standort Giessen, Giessen
Universitaetsklinikum Essen, Zentrum fuer Innere Medizin, Klinik fuer Kardiologie, Essen
Henry Ford Hospital, Detroit
Rabin Medical Centre, Petah Tikva
Hopital Adules Brabois, Vandœuvre-lès-Nancy
Clinique des Maladies Respiratoires, Lille
Hopital Claude Huriez, Lille
Universitaetsklinikum des Saarlandes, Innere Medizin V, Homburg
Baylor College of Medicine, Houston
The Methodist Hospital, Houston
Diagnostics Research Group, San Antonio
Cardiologia, Azienda Ospedaliera Monaldi, Seconda Università di Napoli, Napoli
Med. Klinik u. Poliklinik I der LMU Muenchen, Klinikum Grosshadern, München
West Los Angeles VA Healthcare, Pulmonary Hypertension Program, Los Angeles
Praxis fuer Innere Medizin, Kardiologie und Angiologie, Nuremberg
II. Medizinische Klinik, Kardiologie, Angiologie und Pneumologie, Coburg
Missionsaerztliche Klinik Wuerzburg, Gemeinnuetzige Gesellschaft mbH, Würzburg
Vseobecna fakultni nemocnice v Praze, Prague
Institut klinicke a experimentalni mediciny, Klinika kardiologie, Prague
Medizinische Klinik und Poliklinik I, Universitaetsklinikum Leipzig, Leipzig
Unita' di Ipertensione Polmonare, Dipartimento di Scienze Respiratorie e Cardiovascolari, Roma
PVDU, Papworth Everard
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
INDUSTRY